Akira Yoshida Selected Research

Akira Yoshida Research Topics

Disease

28	Neoplasms (Cancer) 05/2022 - 01/2003
14	Leukemia 10/2014 - 05/2002
12	Type 2 Diabetes Mellitus (MODY) 12/2021 - 09/2013
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2014 - 01/2003
8	Esophageal Achalasia (Megaesophagus) 07/2021 - 11/2011
8	Neoplasm Metastasis (Metastasis) 07/2016 - 02/2009
7	Carcinoma (Carcinomatosis) 08/2013 - 11/2003
5	Adenoma (Adenomas) 01/2022 - 01/2008
5	Insulin Resistance 12/2021 - 01/2015
5	Body Weight (Weight, Body) 12/2021 - 01/2018
5	Thyroid Neoplasms (Thyroid Cancer) 09/2021 - 09/2006
5	Anaplastic Thyroid Carcinoma 01/2020 - 05/2005
5	Infarction (Infarctions) 01/2017 - 03/2007
5	Overactive Urinary Bladder (Overactive Bladder) 01/2016 - 08/2009
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2014
4	Disease Progression 09/2014 - 07/2012
4	Breast Neoplasms (Breast Cancer) 08/2013 - 02/2009
3	Pain (Aches) 05/2021 - 05/2017
3	Pathologic Constriction (Stenosis) 01/2021 - 04/2012
3	Diabetic Retinopathy (Retinopathy, Diabetic) 02/2017 - 09/2013
3	Infections 04/2016 - 03/2010
3	Tumor Lysis Syndrome 05/2015 - 10/2014
3	Hematologic Neoplasms (Hematological Malignancy) 05/2015 - 10/2014
3	Thrombosis (Thrombus) 01/2013 - 01/2010
3	Cerebral Infarction 01/2013 - 03/2007
3	Papillary Carcinoma 11/2012 - 11/2003
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2012 - 01/2003
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2010 - 05/2002
2	Exanthema (Rash) 02/2022 - 03/2010
2	Paralysis (Palsy) 01/2022 - 03/2007
2	Chronic Renal Insufficiency 11/2020 - 04/2019
2	Multiple Myeloma 12/2017 - 10/2013
2	Peritonitis 11/2017 - 08/2013
2	Bone Resorption 09/2017 - 05/2017
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2015 - 11/2012
2	Atopic Dermatitis (Atopic Eczema) 12/2014 - 04/2003
2	Hypoxia (Hypoxemia) 10/2013 - 10/2006
2	Hematologic Diseases (Blood Diseases) 04/2013 - 10/2012
2	Refractory Anemia 09/2012 - 01/2003
2	Disseminated Intravascular Coagulation 01/2011 - 01/2010

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 03/2007
7	SurvivinIBA 12/2017 - 01/2003
6	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 10/2003
6	Messenger RNA (mRNA)IBA 08/2013 - 01/2003
5	SodiumIBA 11/2020 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2003
4	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2021 - 01/2018
4	dapagliflozinIBA 08/2018 - 06/2018
4	Uric Acid (Urate)IBA 05/2015 - 09/2013
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2014 - 08/2009
4	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2013 - 02/2007
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2005 - 01/2003
3	AcidsIBA 05/2022 - 05/2020
3	AntibodiesIBA 05/2022 - 11/2003
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 06/2015
3	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2017
3	Insulin (Novolin)FDA Link 05/2020 - 01/2015
3	SymportersIBA 08/2018 - 01/2018
3	GlucocorticoidsIBA 07/2018 - 05/2002
3	Muscarinic AntagonistsIBA 01/2016 - 01/2010
3	Inhibitor of Apoptosis ProteinsIBA 05/2013 - 01/2003
3	Pharmaceutical PreparationsIBA 10/2012 - 09/2002
3	Glutathione (Reduced Glutathione)IBA 03/2010 - 05/2002
3	Caspase 3 (Caspase-3)IBA 01/2006 - 05/2002
2	lenvatinibIBA 09/2021 - 01/2020
2	CytokinesIBA 07/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2017
2	AlbuminsIBA 01/2021 - 06/2018
2	Biological ProductsIBA 05/2020 - 06/2012
2	Indicators and Reagents (Reagents)IBA 12/2019 - 10/2016
2	Hemoglobins (Hemoglobin)IBA 04/2019 - 08/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2018 - 02/2015
2	AntigensIBA 01/2018 - 10/2011
2	sepantroniumIBA 12/2017 - 05/2013
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 09/2017 - 05/2017
2	elcatoninIBA 09/2017 - 05/2017
2	IodineIBA 07/2016 - 11/2012
2	LDL CholesterolIBA 01/2016 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 06/2015
2	Solifenacin Succinate FDA Link 01/2016 - 08/2009
2	Rituximab (Mabthera)FDA Link 02/2015 - 08/2005
2	Prednisolone (Predate)FDA LinkGeneric 02/2015 - 05/2003
2	Vincristine (Oncovin)FDA LinkGeneric 02/2015 - 05/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 05/2003
2	Xanthine OxidaseIBA 12/2014 - 10/2014
2	Febuxostat FDA Link 12/2014 - 10/2014
2	Small Interfering RNA (siRNA)IBA 10/2013 - 05/2005
2	Nucleic AcidsIBA 09/2013 - 09/2012
2	Rose BengalIBA 01/2013 - 01/2013
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2013 - 03/2007
2	Capecitabine (Xeloda)FDA Link 11/2012 - 02/2009

Therapy/Procedure

24	Therapeutics 06/2022 - 07/2002
10	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
7	Myotomy 01/2021 - 11/2011
4	Activities of Daily Living (ADL) 01/2022 - 07/2002
3	Glycemic Control 06/2018 - 02/2017
3	Thyroidectomy 08/2014 - 01/2011
2	Lasers (Laser) 05/2020 - 12/2011
2	Conservative Treatment 01/2019 - 03/2010
2	Radiotherapy 09/2014 - 05/2009